Pharma Journalist - Page 39 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

FDA Approves First Subcutaneous Therapy for EGFR-Mutated Lung Cancer

FDA Grants Breakthrough Designation to Adrabetadex for Infantile NPC

Telix and Varian Partner to Advance Theranostic-Driven Cancer Care

Zealand Pharma and OTR Therapeutics Launch Collaboration on Metabolic Drugs

Formation Bio Acquires Global Rights to Next-Gen TYK2 Inhibitor

China Approves First New Progressive Pulmonary Fibrosis Drug in 5 Years

Moderna, Nanexa Sign Deal to Develop Long-Acting Injectable Medicines

China Approves Two Sanofi Drugs for Rare Blood Disorders

Pfizer Reports Strong Phase 3 Results for TUKYSA in HER2+ Breast Cancer

Zydus, Formycon Partner to Bring Keytruda Biosimilar to North America